Study Notes: Disorder‑Specific Severity Measures for Adults Focus: Severity of Acute Stress Symptoms—Adult (National Stressful Events Survey Acute Stress Disorder Short Scale [NSESS]) 1. Introduction Disorder‑specific severity measures are standardized tools designed to assess the intensity of symptoms for particular psychiatric conditions. They provide quantitative data that supports diagnosis, treatment planning, monitoring progress, and evaluating […]

Study Notes: Disorder‑Specific Severity Measures for Adults Focus: Severity of Dissociative Symptoms—Adult (Brief Dissociative Experiences Scale [DES‑B]) 1. Introduction Disorder‑specific severity measures are standardized tools used to assess the intensity of symptoms for particular psychiatric conditions. They provide quantitative data that supports diagnosis, treatment planning, monitoring progress, and evaluating outcomes. For adults, one important tool

Study Notes: Disorder‑Specific Severity Measures for Adults Focus: Level 2—Depression—Adult (PROMIS Emotional Distress—Depression—Short Form) 1. Introduction Patient‑Reported Outcomes Measurement Information System (PROMIS) is a set of measures developed by the NIH to evaluate physical, mental, and social health. PROMIS tools are widely used in clinical practice and research to assess patient‑reported outcomes across conditions. The

Study Notes: Disorder‑Specific Severity Measures for Adults Focus: Level 2—Anger—Adult (PROMIS Emotional Distress—Anger—Short Form) 1. Introduction PROMIS (Patient‑Reported Outcomes Measurement Information System) is a set of measures developed by the NIH to evaluate physical, mental, and social health. PROMIS tools are widely used in clinical practice and research to assess patient‑reported outcomes across conditions. The

Study Notes: Disorder‑Specific Severity Measures for Adults Focus: Level 2—Mania—Adult (Altman Self‑Rating Mania Scale [ASRM]) 1. Introduction Disorder‑specific severity measures are standardized tools used to assess the intensity of symptoms for particular psychiatric conditions. They provide quantitative data that supports diagnosis, treatment planning, monitoring progress, and evaluating outcomes. For adults, one important tool is the

Study Notes: Disorder‑Specific Severity Measures for Adults Focus: Level 2—Anxiety—Adult (PROMIS Emotional Distress—Anxiety—Short Form) 1. Introduction PROMIS (Patient‑Reported Outcomes Measurement Information System) is a set of measures developed by the NIH to evaluate physical, mental, and social health. PROMIS tools are widely used in clinical practice and research to assess patient‑reported outcomes across conditions. The

Study Notes: Disorder‑Specific Severity Measures for Adults Focus: Level 2—Somatic Symptom—Adult (PHQ‑15) 1. Introduction Somatic symptoms are physical complaints that may or may not have a clear medical explanation. They are common in primary care and psychiatric settings and can lead to significant distress and functional impairment. The Patient Health Questionnaire‑15 (PHQ‑15) is a widely

Study Notes: Disorder‑Specific Severity Measures for Adults Focus: Level 2—Sleep Disturbance—Adult (PROMIS Sleep Disturbance—Short Form) 1. Introduction PROMIS (Patient‑Reported Outcomes Measurement Information System) is a set of measures developed by the NIH to evaluate physical, mental, and social health. PROMIS tools are widely used in clinical practice and research to assess patient‑reported outcomes across conditions.

Study Notes: Disorder‑Specific Severity Measures for Adults Focus: Level 2—Repetitive Thoughts and Behaviors—Adult (Adapted from FOCI Severity Scale Part B) 1. Introduction Disorder‑specific severity measures are standardized tools designed to assess the intensity of symptoms for particular psychiatric conditions. They provide quantitative data that supports diagnosis, treatment planning, monitoring progress, and evaluating outcomes. For adults,

Study Notes: Disorder‑Specific Severity Measures for Adults Focus: Level 2—Substance Use—Adult (Adapted from the NIDA‑Modified ASSIST) 1. Introduction Substance use disorders (SUDs) are among the most prevalent psychiatric and public health problems worldwide. They involve maladaptive patterns of alcohol, tobacco, or drug use leading to clinically significant impairment or distress. The NIDA‑Modified Alcohol, Smoking, and